GED0301: Clinical Trials

3 completed, 3 terminated, 1 withdrawn. 3 Phase 3, 2 Phase 1, 2 Phase 2.

By phase and status

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease GED-0301, Placebo - Crohn Disease	Phase 3	Withdrawn	Celgene		2017-12-01	2017-11-14
A Study to Evaluate the Effect of Food, Formulation Strength, and a Proton Pump Inhibitor on GED 0301 Pharmacokinetics in Healthy Adult Subjects GED-0301, Omeprazole - Healthy Volunteers	Phase 1	Completed	Celgene	18	2016-11-01	2017-01-12
A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease GED-0301, Placebo - Crohn's Disease	Phase 3	Terminated	Celgene	310	2016-07-25	2019-01-29
Pharmacodynamic and Clinical Outcome Study of Mongersen in Patients With Crohn's Disease GED-0301 - Crohn's Disease	Phase 2	Terminated	Celgene	18	2016-04-04	2018-08-14
An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis GED-0301 - Colitis, Ulcerative	Phase 2	Completed	Celgene	41	2015-12-14	2018-10-17
Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease GED-0301, Placebo - Crohn Disease	Phase 3	Terminated	Celgene	701	2015-12-08	2019-08-28
A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease GED-0301, Placebo - Crohn Disease	Phase 1	Completed	Celgene	64	2015-04-08	2019-01-10